(Q36977766)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17952653%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

review article

1 reference

title

Cannabinoids and neuroprotection in basal ganglia disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17952653%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17952653%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Moisés García-Arencibia

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17952653%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Eva de Lago

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17952653%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Alessandra Decio

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17952653%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Simone Finetti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17952653%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Javier Fernández-Ruiz

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17952653%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

23 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17952653%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

published in

Molecular Neurobiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17952653%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17952653%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17952653%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

82-91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17952653%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12035-007-0004-3

9 January 2020

exact match

0 references

cites work

Serum resistin increases in a postprandial state during liquid meal challenge test in healthy human subjects.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12035-007-0004-3

Early and progressive accumulation of reactive microglia in the Huntington disease brain

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12035-007-0004-3

CB1 cannabinoid receptor induction in experimental stroke

21 January 2018

1 reference

12 December 2020

Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration

1 reference

12 December 2020

Acute neuronal injury, excitotoxicity, and the endocannabinoid system

1 reference

12 December 2020

Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission

1 reference

12 December 2020

The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects.

1 reference

12 December 2020

Activation of the CB1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity

1 reference

12 December 2020

Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity.

1 reference

12 December 2020

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

1 reference

12 December 2020

Evidence for novel cannabinoid receptors

1 reference

12 December 2020

Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties.

1 reference

12 December 2020

Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia

1 reference

12 December 2020

Control of the cell survival/death decision by cannabinoids

1 reference

12 December 2020

Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors

1 reference

12 December 2020

Cannabinoid signaling in glial cells

1 reference

12 December 2020

Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia.

1 reference

12 December 2020

Cannabinoid control of motor function at the basal ganglia.

1 reference

12 December 2020

Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission.

1 reference

12 December 2020

Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies.

1 reference

12 December 2020

Death of cortical and striatal neurons induced by mitochondrial defect involves differential molecular mechanisms

1 reference

12 December 2020

The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders

1 reference

12 December 2020

Modulation of transmitter release via presynaptic cannabinoid receptors

1 reference

12 December 2020

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

1 reference

12 December 2020

Blockade of cannabinoid CB(1) receptor function protects against in vivo disseminating brain damage following NMDA-induced excitotoxicity.

1 reference

12 December 2020

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants

1 reference

12 December 2020

Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease

1 reference

12 December 2020

Mitochondrial defect in Huntington's disease caudate nucleus

1 reference

12 December 2020

Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington's disease

1 reference

12 December 2020

Pathogenesis of Parkinson's disease

1 reference

12 December 2020

Neuroprotective effects of M826, a reversible caspase-3 inhibitor, in the rat malonate model of Huntington's disease

1 reference

12 December 2020

Effects of cannabinoids in the rat model of Huntington's disease generated by an intrastriatal injection of malonate

1 reference

12 December 2020

Treatment of Parkinson's with L-DOPA. The early discovery phase, and a comment on current problems

1 reference

12 December 2020

Inflammation in Parkinson's disease.

1 reference

12 December 2020

Human brain capillary endothelium: 2-arachidonoglycerol (endocannabinoid) interacts with endothelin-1

1 reference

12 December 2020

Release of fatty acid amides in a patient with hemispheric stroke: a microdialysis study

1 reference

12 December 2020

In vivo calpain/caspase cross-talk during 3-nitropropionic acid-induced striatal degeneration: implication of a calpain-mediated cleavage of active caspase-3.

1 reference

12 December 2020

Neuroprotective and antioxidant activities of HU-211, a novel NMDA receptor antagonist

1 reference

12 December 2020

Neuroprotection and neurodegenerative diseases: from biology to clinical practice

1 reference

12 December 2020

Clinical aspects of Parkinson disease

1 reference

12 December 2020

Neuromodulatory functions of the endocannabinoid system

1 reference

12 December 2020

The therapeutic potential of the cannabinoids in neuroprotection

1 reference

12 December 2020

Formation of N-acyl-phosphatidylethanolamine and N-acylethanolamine (including anandamide) during glutamate-induced neurotoxicity

1 reference

12 December 2020

Functional changes of the basal ganglia circuitry in Parkinson's disease.

1 reference

12 December 2020

Putative neuroprotective actions of N-acyl-ethanolamines

1 reference

12 December 2020

A cell-based screen for drugs to treat Huntington's disease

1 reference

12 December 2020

Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease.

1 reference

12 December 2020

Cannabinoid signalling

1 reference

12 December 2020

Changes in cytokines and neurotrophins in Parkinson's disease

1 reference

12 December 2020

Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.

1 reference

12 December 2020

Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures

1 reference

12 December 2020

Cardiovascular effects of cannabinoids

1 reference

12 December 2020

Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in vivo.

1 reference

12 December 2020

Cannabinoids protect cells from oxidative cell death: a receptor-independent mechanism.

1 reference

12 December 2020

Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington's disease mice

1 reference

12 December 2020

Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases.

1 reference

12 December 2020

CB1 cannabinoid receptors and on-demand defense against excitotoxicity

1 reference

12 December 2020

The endocannabinoid system: a physiological perspective on its role in psychomotor control

1 reference

12 December 2020

Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease

1 reference

12 December 2020

The Endocannabinoid System and Huntingtons Disease

1 reference

12 December 2020

Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1.

1 reference

12 December 2020

Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease

1 reference

12 December 2020

Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains

1 reference

12 December 2020

Exogenous anandamide protects rat brain against acute neuronal injury in vivo.

1 reference

12 December 2020

Effects of cannabinoids on energy metabolism.

1 reference

12 December 2020

The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease

1 reference

12 December 2020

Cannabis in movement disorders

1 reference

12 December 2020

Cannabinoids and brain injury: therapeutic implications

1 reference

12 December 2020

Cannabinoid CB1 antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonism

1 reference

12 December 2020

Plant-derived, synthetic and endogenous cannabinoids as neuroprotective agents. Non-psychoactive cannabinoids, 'entourage' compounds and inhibitors of N-acyl ethanolamine breakdown as therapeutic strategies to avoid pyschotropic effects

1 reference

12 December 2020

Cardiovascular actions of cannabinoids and their generation during shock

1 reference

12 December 2020

Cannabinoid CB2 receptor: a new target for controlling neural cell survival?

1 reference

12 December 2020

Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice

1 reference

12 December 2020

Compounds blocking mutant huntingtin toxicity identified using a Huntington's disease neuronal cell model

1 reference

12 December 2020

Cannabinoids and neuroinflammation

1 reference

12 December 2020

The cannabinoid receptor agonist WIN 55,212-2 attenuates the effects induced by quinolinic acid in the rat striatum.

1 reference

12 December 2020

Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease

1 reference

12 December 2020

Brain cannabinoid systems as targets for the therapy of neurological disorders

1 reference

12 December 2020

10.1007/S12035-007-0004-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17952653%20AND%20SRC:MED&resulttype=core&format=json

release_eurrmpbyn5flxbh7oudxlym3qq

9 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/eurrmpbyn5flxbh7oudxlym3qq

24 November 2022

mapped directly with Wikidata item

1 reference